Variant report
Variant | nsv916964 |
---|---|
Chromosome Location | chr14:20691437-20716830 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:185)
- CpG islands (count:429)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:20710881-20710931 | HCF | heart: | n/a |
2 | chr14:20692622-20692672 | GM12891 | blood: | n/a |
3 | chr14:20710881-20710931 | HCF | heart: | n/a |
4 | chr14:20692622-20692672 | GM12891 | blood: | n/a |
5 | chr14:20710315-20710365 | ProgFib | skin: | n/a |
6 | chr14:20711344-20711394 | PrEC | prostate: | n/a |
7 | chr14:20710881-20710931 | ovcar-3 | ovarian: | n/a |
8 | chr14:20710315-20710365 | AG09309 | skin: | n/a |
9 | chr14:20710905-20710955 | HPAEpiC | pulmonary alveolar: | n/a |
10 | chr14:20710315-20710365 | NT2-D1 | testis: | n/a |
11 | chr14:20710905-20710955 | IMR90 | lung: | fetal |
12 | chr14:20710315-20710365 | MCF-7 | breast: | n/a |
13 | chr14:20710881-20710931 | SK-N-SH | brain: | n/a |
14 | chr14:20710881-20710931 | HNPCEpiC | eye: | n/a |
15 | chr14:20691777-20691827 | Jurkat | blood: | n/a |
16 | chr14:20710905-20710955 | HL-60 | blood: | n/a |
17 | chr14:20691777-20691827 | GM12892 | blood: | n/a |
18 | chr14:20710315-20710365 | HCT-116 | colon: | n/a |
19 | chr14:20711344-20711394 | U87 | brain: | n/a |
20 | chr14:20704361-20704411 | HUVEC | blood vessel: | n/a |
21 | chr14:20710905-20710955 | NHDF-neo | bronchial: | n/a |
22 | chr14:20710905-20710955 | AG09309 | skin: | n/a |
23 | chr14:20704361-20704411 | BJ | skin: | n/a |
24 | chr14:20710315-20710365 | HCF | heart: | n/a |
25 | chr14:20710315-20710365 | SK-N-SH_RA | brain: | n/a |
26 | chr14:20710881-20710931 | HIPEpiC | eye: | n/a |
27 | chr14:20692622-20692672 | ECC-1 | luminal epithelium: | n/a |
28 | chr14:20710905-20710955 | GM12878 | blood: | n/a |
29 | chr14:20711344-20711394 | HNPCEpiC | eye: | n/a |
30 | chr14:20704361-20704411 | ovcar-3 | ovarian: | n/a |
31 | chr14:20704361-20704411 | U87 | brain: | n/a |
32 | chr14:20710315-20710365 | BJ | skin: | n/a |
33 | chr14:20691777-20691827 | A549 | lung: | n/a |
34 | chr14:20692622-20692672 | HEK293 | kidney: | embryo |
35 | chr14:20710881-20710931 | ECC-1 | luminal epithelium: | n/a |
36 | chr14:20691777-20691827 | GM19239 | blood: | n/a |
37 | chr14:20692622-20692672 | Caco-2 | colon: | n/a |
38 | chr14:20710315-20710365 | GM19239 | blood: | n/a |
39 | chr14:20710315-20710365 | RPTEC | kidney: | n/a |
40 | chr14:20710315-20710365 | Jurkat | blood: | n/a |
41 | chr14:20704361-20704411 | NT2-D1 | testis: | n/a |
42 | chr14:20710315-20710365 | GM06990 | blood: | n/a |
43 | chr14:20711344-20711394 | H1-hESC | embryonic stem cell: | embryo |
44 | chr14:20710881-20710931 | AG10803 | skin: | n/a |
45 | chr14:20710881-20710931 | NH-A | brain: | n/a |
46 | chr14:20691777-20691827 | HL-60 | blood: | n/a |
47 | chr14:20711344-20711394 | NB4 | blood: | n/a |
48 | chr14:20711344-20711394 | A549 | lung: | n/a |
49 | chr14:20710905-20710955 | HepG2 | liver: | n/a |
50 | chr14:20691777-20691827 | HNPCEpiC | eye: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR11H6 | TF binding region |
OR11H4 | TF binding region |
OR11H7 | TF binding region |
OR11H6 | CpG island |
OR11H4 | CpG island |
OR11H7 | CpG island |
ENSG00000176219 | chromatin interactions |
ENSG00000258806 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141911436 | chr14:20691443-20691444 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs78304232 | chr14:20691447-20691448 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs376089220 | chr14:20691506-20691507 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs188372764 | chr14:20691524-20691525 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs2184671 | chr14:20691525-20691526 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs557944380 | chr14:20691528-20691529 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs150560524 | chr14:20691572-20691573 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs10498266 | chr14:20691610-20691611 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs180734082 | chr14:20691653-20691654 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs17211264 | chr14:20691662-20691663 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs185834360 | chr14:20691664-20691665 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs139595522 | chr14:20691665-20691666 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs17106268 | chr14:20691718-20691719 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs572055742 | chr14:20691726-20691727 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs546378303 | chr14:20691736-20691737 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs45501895 | chr14:20691752-20691753 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs545054617 | chr14:20691760-20691761 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs144469985 | chr14:20691766-20691767 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs200572314 | chr14:20691772-20691773 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs79648471 | chr14:20691777-20691778 | Enhancers | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs368646757 | chr14:20691826-20691827 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs147433998 | chr14:20691855-20691856 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs565599003 | chr14:20691861-20691862 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs148940765 | chr14:20691881-20691882 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs10140652 | chr14:20691888-20691889 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs369904054 | chr14:20691891-20691892 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs551257417 | chr14:20691943-20691944 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs569846585 | chr14:20691961-20691962 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs9323693 | chr14:20691962-20691963 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs555887602 | chr14:20691966-20691967 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs141900029 | chr14:20691992-20691993 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs373020363 | chr14:20691994-20691995 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs375505746 | chr14:20692002-20692003 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs147264499 | chr14:20692011-20692012 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs369868397 | chr14:20692026-20692027 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs149861478 | chr14:20692028-20692029 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs111468039 | chr14:20692044-20692045 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs143195914 | chr14:20692076-20692077 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs553013613 | chr14:20692082-20692083 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs201233405 | chr14:20692083-20692084 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs267603920 | chr14:20692087-20692088 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs200550313 | chr14:20692093-20692094 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs145052055 | chr14:20692098-20692099 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs377239717 | chr14:20692101-20692102 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs139409894 | chr14:20692103-20692104 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs267603921 | chr14:20692132-20692133 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs370128507 | chr14:20692177-20692178 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs576558552 | chr14:20692184-20692185 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs12891553 | chr14:20692188-20692189 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs148394506 | chr14:20692208-20692209 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cone-rod dystrophy | 18421352 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 21482944 | CNVD |
Mental retardation | 19951919 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Ependymoma | 20639864 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:20691200-20692600 | Enhancers | K562 | blood |
2 | chr14:20695400-20695600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr14:20698000-20698400 | Active TSS | Fetal Heart | heart |
4 | chr14:20704000-20704400 | Active TSS | HepG2 | liver |
5 | chr14:20707000-20707200 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |